Profit and Loss Results Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
No of Months
12
12
Operating Income
67.00
65.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
67.00
65.00
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-3.00
Raw Materials Consumed
30.00
34.00
Power & Fuel Cost
0.00
0.00
Employee Cost
10.00
11.00
Operating Expenses
6.00
6.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
7.00
5.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
0.00
0.00
Expenses Capitalised
0.00
0.00
Total Expenditure
64.00
62.00
Operating Profit (PBDIT) excl Other Income
2.00
2.00
Other Income
0.00
0.00
Operating Profit (PBDIT)
2.00
2.00
Interest
0.00
0.00
Profit before Depriciation and Tax
2.00
2.00
Depreciation
0.00
0.00
Profit Before Taxation & Exceptional Items
2.00
2.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
2.00
2.00
Provision for Tax
0.00
0.00
Profit After Tax
1.00
1.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
7.00
6.00
Profit Available for appropriations
9.00
8.00
Appropriations
9.00
8.00
Equity Dividend (%)
8.00%
0.00%
Earnings Per Share
1.51
1.62
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 2.96% vs NA in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is -7.65% vs NA in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is -20.73% vs NA in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is -3.90% vs NA in Mar 2023
Compare Profit and Loss Results of Sandu Pharma.
Figures in Rs cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
67.00
1,527.00
-1,460.00
-95.61%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
67.00
1,527.00
-1,460.00
-95.61%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-9.00
10.00
111.11%
Raw Materials Consumed
30.00
1,307.00
-1,277.00
-97.70%
Power & Fuel Cost
0.00
5.00
-5.00
-100.00%
Employee Cost
10.00
70.00
-60.00
-85.71%
Operating Expenses
6.00
10.00
-4.00
-40.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
0.00
7.00
0%
Cost of Software developments
0.00
1.00
-1.00
-100.00%
Miscellaneous Expenses
0.00
46.00
-46.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
64.00
1,448.00
-1,384.00
-95.58%
Operating Profit (PBDIT) excl Other Income
2.00
78.00
-76.00
-97.44%
Other Income
0.00
18.00
-18.00
-100.00%
Operating Profit (PBDIT)
2.00
97.00
-95.00
-97.94%
Interest
0.00
8.00
-8.00
-100.00%
Profit before Depriciation and Tax
2.00
89.00
-87.00
-97.75%
Depreciation
0.00
17.00
-17.00
-100.00%
Profit Before Taxation & Exceptional Items
2.00
71.00
-69.00
-97.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
76.00
-74.00
-97.37%
Provision for Tax
0.00
19.00
-19.00
-100.00%
Profit After Tax
1.00
52.00
-51.00
-98.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
7.00
257.00
-250.00
-97.28%
Profit Available for appropriations
9.00
314.00
-305.00
-97.13%
Appropriations
9.00
314.00
-305.00
-97.13%
Equity Dividend (%)
8%
0%
8.00
Earnings Per Share
1.51
6.62
-5.11
-77.19%
Profit And Loss - Net Sales
Net Sales 67.28 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 2.96% vs NA in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.30 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -7.65% vs NA in Mar 2023
Profit And Loss - Interest
Interest 0.06 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -20.73% vs NA in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 1.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -3.90% vs NA in Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
